Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Best Case Scenario: ``... putting Patriot`s maximum take closer to $1 billion...``

Best Case Scenario: ``... putting Patriot`s maximum take closer to $1 billion...``

posted on Apr 21, 2006 03:30PM
What speculator/investor unaware wouldn`t find this appealing?

*******

``Assuming, perhaps generously, it can tap nearly all the companies on its licensing wish list for the average fee it has commanded so far, about $15 million, more than $2 billion could be within reach. But to resolve costly litigation, last summer Patriot reached an agreement with TPL to unify the pair`s patent portfolio and create one force to pursue licensing fees, overcoming a major hurdle but with a significant cost to Patriot and its investors.

Patriot`s claim on the patents came from a man named Russell Fish, whose rights it owns, while TPL`s claims came from a deal struck with Fish`s partner, Charles Moore. Under the deal, the groups will split licensing revenue in half, putting Patriot`s maximum take closer to $1 billion.``

Beats most otcbbs lurking out there...for a buck?

Share
New Message
Please login to post a reply